Clinical trial
A Double-blind, Randomised, Parallel Groups Investigation Into the Effects of Pregabalin, Duloxetine and Amitriptyline on Aspects of Pain, Sleep, and Next Day Performance in Patients Suffering From Diabetic Peripheral Neuropathy
NCT00370656 is registered in ClinicalTrials.gov with University of Surrey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomised, Parallel Groups Investigation Into the Effects of Pregabalin, Duloxetine and Amitriptyline on Aspects of Pain, Sleep, and Next Day Performance in Patients Suffering From Diabetic Peripheral Neuropathy
- Lead sponsor
- University of Surrey
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- May 31, 2009
- Enrollment
- 90 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, peripheral neuropathies